Genedx Holdings Corp. income statement

In fiscal 2025, Genedx Holdings Corp. reported revenue of $428m, up 40.0% on the year before, operating income of −$13.1m (a -3.1% margin) and net income of −$21.0m, or −$0.73 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Genedx Holdings Corp.: income statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	196	179	212	235	203	305	428	454
Cost of revenue	113	175	229	261	113	111	129	139
Gross profit	83	4	−17	−27	90	194	298	315
Research and development	35	73	105	86	58	46	72	84
Selling and marketing	39	63	113	122	61	67	88	—
General and administrative	29	101	206	216	139	105	151	—
Operating income	−30	−242	−446	−668	−181	−23	−13	−92
Interest expense	1	2	3	3	—	—	—	—
Net interest income	—	—	—	−1	1	—	—	—
Income before tax	−30	−241	−245	−598	−177	−53	−21	−106
Income tax	0	0	0	−49	−1	−0	−0	0
Net income	−30	−241	−245	−549	−176	−52	−21	−106
Diluted EPS	−$2904616.00	−$517396.00	−$24.97	−$53.63	−$7.23	−$1.94	−$0.73	−$3.68
Diluted shares (average)	—	466m	10m	10m	24m	27m	29m	29m
EBITDA	−24	−230	−424	−618	−161	−15	−3	−81

US$ millions unless shown otherwise. Fiscal quarters.

Genedx Holdings Corp.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	77	96	87	103	117	121	102	114
Cost of revenue	29	29	29	32	32	37	34	36
Gross profit	48	66	58	71	85	84	68	78
Research and development	12	12	13	15	20	25	20	20
Selling, general and administrative	—	—	50	47	—	—	75	76
Selling and marketing	17	18	—	—	24	27	—	—
General and administrative	27	28	—	—	44	47	—	—
Operating income	−8	9	−5	9	−3	−14	−57	−17
Income before tax	−8	5	−6	11	−7	−18	−62	−18
Income tax	−0	−0	0	−0	0	−1	1	−1
Net income	−8	5	−7	11	−8	−18	−63	−18
Diluted EPS	−$0.31	$0.23	−$0.23	$0.36	−$0.27	−$0.61	−$2.16	−$0.60
EBITDA	−5	11	−2	11	−1	−11	−55	−14

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PHR vs WGS HSTM vs WGS DOCS vs WGS

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Genedx Holdings Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Genedx Holdings Corp.